InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Trowbridge Stephen A, Chief Financial Officer. Director active across 1 companies, notably Angiodynamics INC. Aggregated, 12 reports have been recorded. Total volume traded: €40k. The latest transaction was filed on 3 February 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Declarations12 total
€10,566583 shares@ €18.1240.0024% mcap7.9% of flow
Common Stock
SEC:0001567619-22-002518:0·
€10,566583 shares@ €18.1240.0024% mcap15.8% of flow
Common Stock
SEC:0001567619-22-002518·
€19,9181,000 shares@ €19.91820.0045% mcap29.7% of flow
Common Stock
SEC:0001567619-22-001116·
Ideal exit: 9 Oct 2022 (T+270)
€19,9181,000 shares@ €19.91820.0045% mcap14.9% of flow
Common Stock
SEC:0001567619-22-001116:0·
Ideal exit: 9 Oct 2022 (T+270)
010,946 shares0
Common Stock
SEC:0001567619-21-016021·
010,946 shares0
Common Stock
SEC:0001567619-21-016021:0·
03,231 shares0
Common Stock
SEC:0001567619-21-015946·
03,231 shares0
Common Stock
SEC:0001567619-21-015946:0·
€7,803353 shares@ €22.10410.0018% mcap11.7% of flow
Common Stock
SEC:0001567619-21-014062·
€7,803353 shares@ €22.10410.0018% mcap5.8% of flow
Common Stock
SEC:0001567619-21-014062:0·
€28,6781,284 shares@ €22.33520.0064% mcap42.8% of flow
Common Stock
SEC:0001567619-21-013929·
€28,6781,284 shares@ €22.33520.0064% mcap21.4% of flow
Common Stock
SEC:0001567619-21-013929:0·
12 of 12 declarations
About Trowbridge Stephen A
Stephen A. Trowbridge is the Executive Vice President and Chief Financial Officer of AngioDynamics Inc. He oversees the financial management of the company, including budget planning and financial reporting. His role is essential in ensuring AngioDynamics's financial health.
